Pulse Biosciences, Inc.
PLSE
$16.56
-$0.4899-2.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.90% | -19.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.36% | -10.94% | |||
| Operating Income | -12.36% | 10.94% | |||
| Income Before Tax | -14.13% | 13.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.13% | 13.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.13% | 13.36% | |||
| EBIT | -12.36% | 10.94% | |||
| EBITDA | -12.62% | 11.08% | |||
| EPS Basic | -13.87% | 19.91% | |||
| Normalized Basic EPS | -13.87% | 19.88% | |||
| EPS Diluted | -13.87% | 19.91% | |||
| Normalized Diluted EPS | -13.87% | 19.88% | |||
| Average Basic Shares Outstanding | 0.22% | 8.17% | |||
| Average Diluted Shares Outstanding | 0.22% | 8.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||